Rana Sugars Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 4, 2025, 8:07 pm

Market Cap	246 Cr.
Current Price	16.0
High / Low	27.8/11.1
Stock P/E	7.14
Book Value	37.5
Dividend Yield	0.00 %
ROCE	8.02 %
ROE	6.32 %
Face Value	10.0
PEG Ratio	-0.27

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Rana Sugars Ltd

Competitors of Rana Sugars Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gayatri Sugars Ltd	89.5 Cr.	12.0	26.5/7.02	83.7	11.4	0.00 %	36.6 %	%	10.0
Dhampure Speciality Sugars Ltd	84.6 Cr.	102	142/78.0	31.3	41.0	0.00 %	11.6 %	8.88 %	10.0
Dhampur Bio Organics Ltd	554 Cr.	83.5	164/57.3	35.2	152	1.47 %	3.97 %	1.56 %	10.0
DCM Shriram Industries Ltd	1,433 Cr.	165	232/142	14.1	103	1.21 %	13.8 %	11.8 %	2.00
Davangere Sugar Company Ltd	327 Cr.	3.48	10.2/2.81	29.9	3.64	0.00 %	6.80 %	3.22 %	1.00
Industry Average	2,063.78 Cr	297.86		32.74	229.98	0.68%	8.73%	7.97%	6.37

All Competitor Stocks of Rana Sugars Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	486	427	378	370	452	500	340	337	415	462	386	390	475
Expenses	425	404	370	346	394	467	345	319	379	443	393	371	435
Operating Profit	62	23	8	25	58	33	-5	18	36	20	-8	20	40
OPM %	13%	5%	2%	7%	13%	7%	-1%	5%	9%	4%	-2%	5%	8%
Other Income	2	9	4	1	9	4	6	3	6	3	2	9	20
Interest	16	5	4	4	10	8	6	5	9	11	7	6	9
Depreciation	7	7	7	7	9	8	8	8	11	9	9	-1	10
Profit before tax	40	20	1	14	48	21	-13	7	22	3	-23	24	40
Tax %	59%	21%	0%	89%	5%	26%	12%	26%	0%	35%	-34%	40%	0%
Net Profit	17	16	1	2	45	15	-15	6	22	2	-15	14	40
EPS in Rs	1.08	1.02	0.05	0.10	2.95	1.00	-0.95	0.36	1.41	0.12	-0.96	0.92	2.59

Last Updated: May 31, 2025, 7:59 am

Below is a detailed analysis of the quarterly data for Rana Sugars Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 475.00 Cr.. The value appears strong and on an upward trend. It has increased from 390.00 Cr. (Dec 2024) to 475.00 Cr., marking an increase of 85.00 Cr..
For Expenses, as of Mar 2025, the value is 435.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 371.00 Cr. (Dec 2024) to 435.00 Cr., marking an increase of 64.00 Cr..
For Operating Profit, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Dec 2024) to 40.00 Cr., marking an increase of 20.00 Cr..
For OPM %, as of Mar 2025, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Dec 2024) to 8.00%, marking an increase of 3.00%.
For Other Income, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Dec 2024) to 20.00 Cr., marking an increase of 11.00 Cr..
For Interest, as of Mar 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Dec 2024) to 9.00 Cr., marking an increase of 3.00 Cr..
For Depreciation, as of Mar 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -1.00 Cr. (Dec 2024) to 10.00 Cr., marking an increase of 11.00 Cr..
For Profit before tax, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 24.00 Cr. (Dec 2024) to 40.00 Cr., marking an increase of 16.00 Cr..
For Tax %, as of Mar 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 40.00% (Dec 2024) to 0.00%, marking a decrease of 40.00%.
For Net Profit, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Dec 2024) to 40.00 Cr., marking an increase of 26.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 2.59. The value appears strong and on an upward trend. It has increased from 0.92 (Dec 2024) to 2.59, marking an increase of 1.67.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:20 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	648	698	856	1,091	977	1,092	1,313	1,222	1,400	1,627	1,593	1,713
Expenses	564	674	717	1,012	940	1,049	1,229	1,095	1,222	1,511	1,506	1,642
Operating Profit	84	24	139	79	37	42	84	126	178	116	87	71
OPM %	13%	3%	16%	7%	4%	4%	6%	10%	13%	7%	5%	4%
Other Income	-0	8	1	2	7	15	231	77	-13	21	14	34
Interest	80	87	95	90	99	94	22	18	29	23	28	34
Depreciation	33	27	28	28	31	33	34	27	28	31	35	27
Profit before tax	-30	-82	17	-38	-87	-69	259	158	109	82	37	44
Tax %	-19%	-33%	-0%	19%	-1%	8%	-3%	-0%	22%	23%	24%	22%
Net Profit	-24	-55	17	-45	-86	-75	266	158	85	63	28	34
EPS in Rs	-1.56	-3.58	1.09	-2.94	-5.63	-4.88	17.30	10.27	5.55	4.13	1.82	2.24
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	-129.17%	130.91%	-364.71%	-91.11%	12.79%	454.67%	-40.60%	-46.20%	-25.88%	-55.56%	21.43%
Change in YoY Net Profit Growth (%)	0.00%	260.08%	-495.61%	273.59%	103.90%	441.88%	-495.27%	-5.60%	20.32%	-29.67%	76.98%

Rana Sugars Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	9%
5 Years:	5%
3 Years:	7%
TTM:	8%

Compounded Profit Growth
10 Years:	10%
5 Years:	-4%
3 Years:	-30%
TTM:	11%

Stock Price CAGR
10 Years:	20%
5 Years:	31%
3 Years:	-15%
1 Year:	-36%

Return on Equity
10 Years:	%
5 Years:	15%
3 Years:	8%
Last Year:	6%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:28 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	154	154	154	154	154	154	154	154	154	154	154	154
Reserves	43	-12	5	-54	-169	-243	23	181	267	331	359	422
Borrowings	810	824	864	841	865	874	303	207	222	412	443	407
Other Liabilities	330	344	417	258	537	562	583	594	648	566	548	539
Total Liabilities	1,336	1,310	1,440	1,199	1,387	1,346	1,064	1,136	1,290	1,462	1,503	1,522
Fixed Assets	453	439	447	455	450	431	378	421	452	521	579	568
CWIP	32	34	29	28	21	30	38	28	57	14	6	6
Investments	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	851	836	964	717	916	886	648	688	781	926	918	948
Total Assets	1,336	1,310	1,440	1,199	1,387	1,346	1,064	1,136	1,290	1,462	1,503	1,522

Below is a detailed analysis of the balance sheet data for Rana Sugars Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 154.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 154.00 Cr..
For Reserves, as of Mar 2025, the value is 422.00 Cr.. The value appears strong and on an upward trend. It has increased from 359.00 Cr. (Mar 2024) to 422.00 Cr., marking an increase of 63.00 Cr..
For Borrowings, as of Mar 2025, the value is 407.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 443.00 Cr. (Mar 2024) to 407.00 Cr., marking a decrease of 36.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 539.00 Cr.. The value appears to be improving (decreasing). It has decreased from 548.00 Cr. (Mar 2024) to 539.00 Cr., marking a decrease of 9.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 1,522.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,503.00 Cr. (Mar 2024) to 1,522.00 Cr., marking an increase of 19.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 568.00 Cr.. The value appears to be declining and may need further review. It has decreased from 579.00 Cr. (Mar 2024) to 568.00 Cr., marking a decrease of 11.00 Cr..
For CWIP, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Mar 2025, the value is 948.00 Cr.. The value appears strong and on an upward trend. It has increased from 918.00 Cr. (Mar 2024) to 948.00 Cr., marking an increase of 30.00 Cr..
For Total Assets, as of Mar 2025, the value is 1,522.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,503.00 Cr. (Mar 2024) to 1,522.00 Cr., marking an increase of 19.00 Cr..

Notably, the Reserves (422.00 Cr.) exceed the Borrowings (407.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	3	92	93	113	160	105	329	146	92	-84	44	55
Cash from Investing Activity +	-17	-15	-27	-36	-63	-28	-36	-62	-123	-98	-51	8
Cash from Financing Activity +	26	-96	-52	-87	-103	-85	-246	-76	-3	170	8	-40
Net Cash Flow	13	-19	14	-10	-7	-8	47	8	-34	-12	1	22

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-726.00	-800.00	-725.00	-762.00	-828.00	-832.00	-219.00	-81.00	-44.00	-296.00	-356.00	-336.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	30	33	30	32	24	52	46	40	41	28	29	32
Inventory Days	411	516	387	401	168	231	207	104	151	196	180	176
Days Payable	143	150	129	163	59	196	202	157	201	201	132	130
Cash Conversion Cycle	298	399	288	270	133	88	51	-12	-9	23	77	78
Working Capital Days	199	262	217	184	118	90	62	1	6	27	70	76
ROCE %	9%	5%	1%	11%	5%	1%	3%	9%	20%	26%	13%	7%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	22.64%	22.64%	22.64%	22.64%	22.64%	22.64%	22.64%	22.64%	22.64%	22.64%	22.64%	22.64%
FIIs	1.90%	2.80%	2.32%	1.96%	0.14%	0.01%	0.00%	1.73%	0.00%	0.03%	0.01%	0.00%
DIIs	0.02%	0.01%	0.02%	0.00%	0.10%	0.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Government	1.66%	1.66%	1.67%	1.67%	1.67%	1.67%	1.66%	1.66%	1.66%	1.66%	1.66%	1.66%
Public	73.78%	72.89%	73.36%	73.75%	75.46%	75.59%	75.70%	73.97%	75.70%	75.66%	75.69%	75.69%
No. of Shareholders	89,009	1,14,096	1,20,243	1,18,513	1,20,549	1,19,414	1,16,079	1,15,468	1,17,682	1,21,863	1,23,147	1,24,717

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	2.24	1.82	4.13	5.55	10.27
Diluted EPS (Rs.)	2.24	1.82	4.13	5.55	10.27
Cash EPS (Rs.)	4.00	4.12	6.17	7.36	12.03
Book Value[Excl.RevalReserv]/Share (Rs.)	37.47	33.37	31.54	27.41	21.82
Book Value[Incl.RevalReserv]/Share (Rs.)	37.47	33.37	31.54	27.41	21.82
Revenue From Operations / Share (Rs.)	111.55	103.73	106.00	91.20	79.59
PBDIT / Share (Rs.)	6.83	6.56	8.90	11.84	8.57
PBIT / Share (Rs.)	5.06	4.25	6.86	10.03	6.81
PBT / Share (Rs.)	2.87	2.41	5.37	7.10	10.26
Net Profit / Share (Rs.)	2.24	1.82	4.13	5.55	10.27
PBDIT Margin (%)	6.12	6.32	8.40	12.97	10.76
PBIT Margin (%)	4.53	4.10	6.47	10.99	8.55
PBT Margin (%)	2.57	2.32	5.06	7.78	12.89
Net Profit Margin (%)	2.00	1.75	3.89	6.08	12.90
Return on Networth / Equity (%)	5.97	5.45	13.09	20.24	47.07
Return on Capital Employeed (%)	10.72	9.41	15.36	25.29	21.67
Return On Assets (%)	2.25	1.86	4.33	6.60	13.87
Long Term Debt / Equity (X)	0.15	0.13	0.18	0.22	0.27
Total Debt / Equity (X)	0.68	0.73	0.72	0.39	0.47
Asset Turnover Ratio (%)	1.13	1.07	1.18	1.15	1.11
Current Ratio (X)	1.12	1.07	1.11	1.11	1.05
Quick Ratio (X)	0.40	0.33	0.35	0.35	0.47
Inventory Turnover Ratio (X)	2.20	2.04	2.33	2.53	2.94
Interest Coverage Ratio (X)	3.12	3.55	5.97	6.30	7.15
Interest Coverage Ratio (Post Tax) (X)	2.02	1.99	3.77	4.52	5.69
Enterprise Value (Cr.)	528.84	668.18	681.88	585.60	249.95
EV / Net Operating Revenue (X)	0.30	0.41	0.41	0.41	0.20
EV / EBITDA (X)	5.04	6.64	4.99	3.22	1.90
MarketCap / Net Operating Revenue (X)	0.10	0.18	0.20	0.31	0.12
Price / BV (X)	0.32	0.57	0.69	1.04	0.44
Price / Net Operating Revenue (X)	0.10	0.18	0.20	0.31	0.12
EarningsYield	0.18	0.09	0.18	0.19	1.07

After reviewing the key financial ratios for Rana Sugars Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 2.24. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 24) to 2.24, marking an increase of 0.42.
For Diluted EPS (Rs.), as of Mar 25, the value is 2.24. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 24) to 2.24, marking an increase of 0.42.
For Cash EPS (Rs.), as of Mar 25, the value is 4.00. This value is within the healthy range. It has decreased from 4.12 (Mar 24) to 4.00, marking a decrease of 0.12.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 37.47. It has increased from 33.37 (Mar 24) to 37.47, marking an increase of 4.10.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 37.47. It has increased from 33.37 (Mar 24) to 37.47, marking an increase of 4.10.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 111.55. It has increased from 103.73 (Mar 24) to 111.55, marking an increase of 7.82.
For PBDIT / Share (Rs.), as of Mar 25, the value is 6.83. This value is within the healthy range. It has increased from 6.56 (Mar 24) to 6.83, marking an increase of 0.27.
For PBIT / Share (Rs.), as of Mar 25, the value is 5.06. This value is within the healthy range. It has increased from 4.25 (Mar 24) to 5.06, marking an increase of 0.81.
For PBT / Share (Rs.), as of Mar 25, the value is 2.87. This value is within the healthy range. It has increased from 2.41 (Mar 24) to 2.87, marking an increase of 0.46.
For Net Profit / Share (Rs.), as of Mar 25, the value is 2.24. This value is within the healthy range. It has increased from 1.82 (Mar 24) to 2.24, marking an increase of 0.42.
For PBDIT Margin (%), as of Mar 25, the value is 6.12. This value is below the healthy minimum of 10. It has decreased from 6.32 (Mar 24) to 6.12, marking a decrease of 0.20.
For PBIT Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 10. It has increased from 4.10 (Mar 24) to 4.53, marking an increase of 0.43.
For PBT Margin (%), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 10. It has increased from 2.32 (Mar 24) to 2.57, marking an increase of 0.25.
For Net Profit Margin (%), as of Mar 25, the value is 2.00. This value is below the healthy minimum of 5. It has increased from 1.75 (Mar 24) to 2.00, marking an increase of 0.25.
For Return on Networth / Equity (%), as of Mar 25, the value is 5.97. This value is below the healthy minimum of 15. It has increased from 5.45 (Mar 24) to 5.97, marking an increase of 0.52.
For Return on Capital Employeed (%), as of Mar 25, the value is 10.72. This value is within the healthy range. It has increased from 9.41 (Mar 24) to 10.72, marking an increase of 1.31.
For Return On Assets (%), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. It has increased from 1.86 (Mar 24) to 2.25, marking an increase of 0.39.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.13 (Mar 24) to 0.15, marking an increase of 0.02.
For Total Debt / Equity (X), as of Mar 25, the value is 0.68. This value is within the healthy range. It has decreased from 0.73 (Mar 24) to 0.68, marking a decrease of 0.05.
For Asset Turnover Ratio (%), as of Mar 25, the value is 1.13. It has increased from 1.07 (Mar 24) to 1.13, marking an increase of 0.06.
For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has increased from 1.07 (Mar 24) to 1.12, marking an increase of 0.05.
For Quick Ratio (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.33 (Mar 24) to 0.40, marking an increase of 0.07.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 4. It has increased from 2.04 (Mar 24) to 2.20, marking an increase of 0.16.
For Interest Coverage Ratio (X), as of Mar 25, the value is 3.12. This value is within the healthy range. It has decreased from 3.55 (Mar 24) to 3.12, marking a decrease of 0.43.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. It has increased from 1.99 (Mar 24) to 2.02, marking an increase of 0.03.
For Enterprise Value (Cr.), as of Mar 25, the value is 528.84. It has decreased from 668.18 (Mar 24) to 528.84, marking a decrease of 139.34.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.41 (Mar 24) to 0.30, marking a decrease of 0.11.
For EV / EBITDA (X), as of Mar 25, the value is 5.04. This value is within the healthy range. It has decreased from 6.64 (Mar 24) to 5.04, marking a decrease of 1.60.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.10, marking a decrease of 0.08.
For Price / BV (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has decreased from 0.57 (Mar 24) to 0.32, marking a decrease of 0.25.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.10, marking a decrease of 0.08.
For EarningsYield, as of Mar 25, the value is 0.18. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.18, marking an increase of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Rana Sugars Ltd as of July 6, 2025 is: 13.81

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of July 6, 2025, Rana Sugars Ltd is Overvalued by 13.69% compared to the current share price 16.00

Intrinsic Value of Rana Sugars Ltd as of July 6, 2025 is: 10.18

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of July 6, 2025, Rana Sugars Ltd is Overvalued by 36.38% compared to the current share price 16.00

Last 5 Year EPS CAGR: -26.25%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has shown consistent growth in sales (265.58 cr) and profit (33.33 cr) over the years.	The stock has a low average ROCE of 9.17%, which may not be favorable. The stock has a high average Working Capital Days of 109.33, which may not be favorable. The stock has a high average Cash Conversion Cycle of 140.33, which may not be favorable. The company has higher borrowings (589.33) compared to reserves (96.08), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Rana Sugars Ltd:
1. Net Profit Margin: 2%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 10.72% (Industry Average ROCE: 8.73%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 5.97% (Industry Average ROE: 7.97%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.02
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.4
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 7.14 (Industry average Stock P/E: 32.74)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.68
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Rana Sugars Ltd. is a Public Limited Listed company incorporated on 30/07/1991 and has its registered office in the State of Chandigarh, India. Company's Corporate Identification Number(CIN) is L15322CH1991PLC011537 and registration number is 011537. Currently Company is involved in the business activities of Manufacture or refining of sugar (sucrose) from sugercane. Company's Total Operating Revenue is Rs. 1712.79 Cr. and Equity Capital is Rs. 153.54 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Sugar	SCO 49-50, Sector 8-C, Chandigarh Chandigarh 160009	info@ranagroup.com http://www.ranasugars.com

Management
Name	Position Held
Mr. Rana Ranjit Singh	Chairman & Non-Exe.Director
Mr. Rana Veer Pratap Singh	Managing Director
Mr. Surjeet Kaushal	Ind. Non-Executive Director
Ms. Navpreet Kaur	Ind. Non-Executive Director
Mr. Harneet Singh Oberoi	Ind. Non-Executive Director
Mr. Basant Kumar Bajaj	Independent Director

FAQ

What is the intrinsic value of Rana Sugars Ltd?

Rana Sugars Ltd's intrinsic value (as of 06 July 2025) is 13.81 — 13.69% lower the current market price of 16.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 246 Cr. market cap, FY2025-2026 high/low of 27.8/11.1, reserves of 422 Cr, and liabilities of 1,522 Cr.

What is the Market Cap of Rana Sugars Ltd?

The Market Cap of Rana Sugars Ltd is 246 Cr..

What is the current Stock Price of Rana Sugars Ltd as on 06 July 2025?

The current stock price of Rana Sugars Ltd as on 06 July 2025 is 16.0.

What is the High / Low of Rana Sugars Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Rana Sugars Ltd stocks is ₹27.8/11.1.

What is the Stock P/E of Rana Sugars Ltd?

The Stock P/E of Rana Sugars Ltd is 7.14.

What is the Book Value of Rana Sugars Ltd?

The Book Value of Rana Sugars Ltd is 37.5.

What is the Dividend Yield of Rana Sugars Ltd?

The Dividend Yield of Rana Sugars Ltd is 0.00 %.

What is the ROCE of Rana Sugars Ltd?

The ROCE of Rana Sugars Ltd is 8.02 %.

What is the ROE of Rana Sugars Ltd?

The ROE of Rana Sugars Ltd is 6.32 %.

What is the Face Value of Rana Sugars Ltd?

The Face Value of Rana Sugars Ltd is 10.0.